🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
9.38
-0.22 (-2.29%)
At close: Nov 18, 2026, 4:00 PM EST
9.24
-0.14 (-1.49%)
Pre-market: Nov 19, 2026, 4:01 AM EST

Bicara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
623922948--
Market Cap Growth
-23.09%-2.74%---
Enterprise Value
181634428--
Last Close Price
9.3816.8317.42--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
1.522.301.93--
P/TBV Ratio
1.522.301.93--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.000.000.000.00-
Net Debt / Equity Ratio
-1.08-1.03-0.99-1.050.24
Net Debt / EBITDA Ratio
1.862.665.945.760.11
Net Debt / FCF Ratio
2.713.866.544.970.13
Quick Ratio
8.6314.3327.2215.280.17
Current Ratio
8.8114.5827.9315.320.21
Return on Equity (ROE)
-54.24%-30.88%-19.14%-51.67%-
Return on Assets (ROA)
-33.47%-20.67%-13.84%-20.72%-
Return on Capital Employed (ROCE)
-57.90%-38.70%-16.70%-18.20%219.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-37.23%-14.96%-7.17%--
FCF Yield
-26.14%-11.62%-7.89%--
Buyback Yield / Dilution
-15.60%-225.35%-2796.96%-35.20%-
SEC Filings: 10-K · 10-Q